BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 20883750)

  • 1. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicatechin inhibits radiation-induced auditory cell death by suppression of reactive oxygen species generation.
    Pyun JH; Kang SU; Hwang HS; Oh YT; Kang SH; Lim YA; Choo OS; Kim CH
    Neuroscience; 2011 Dec; 199():410-20. PubMed ID: 21946009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicatechin protects auditory cells against cisplatin-induced death.
    Kim CH; Kang SU; Pyun J; Lee MH; Hwang HS; Lee H
    Apoptosis; 2008 Sep; 13(9):1184-94. PubMed ID: 18670884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
    Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
    Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiapoptotic mechanism of cannabinoid receptor 2 agonist on cisplatin-induced apoptosis in the HEI-OC1 auditory cell line.
    Jeong HJ; Kim SJ; Moon PD; Kim NH; Kim JS; Park RK; Kim MS; Park BR; Jeong S; Um JY; Kim HM; Hong SH
    J Neurosci Res; 2007 Mar; 85(4):896-905. PubMed ID: 17183590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
    Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
    Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
    J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
    García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
    J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
    Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
    J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective mechanism of Korean Red Ginseng in cisplatin-induced ototoxicity through attenuation of nuclear factor-κB and caspase-1 activation.
    Kim SJ; Kwak HJ; Kim DS; Choi HM; Sim JE; Kim SH; Um JY; Hong SH
    Mol Med Rep; 2015 Jul; 12(1):315-22. PubMed ID: 25738645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
    Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
    Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
    Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
    Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p38 mitogen-activated protein kinase ameliorates radiation-induced ototoxicity in zebrafish and cochlea-derived cell lines.
    Shin YS; Hwang HS; Kang SU; Chang JW; Oh YT; Kim CH
    Neurotoxicology; 2014 Jan; 40():111-22. PubMed ID: 24374476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proapoptotic effects of NF-kappaB on cisplatin-induced cell death in auditory cell line.
    Chung WH; Boo SH; Chung MK; Lee HS; Cho YS; Hong SH
    Acta Otolaryngol; 2008 Oct; 128(10):1063-70. PubMed ID: 18607991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
    Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
    Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.